Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia

Biological Psychiatry

Volumn 47, Issue 1, 2000, Pages 80-83

  Burnet, Philip W J ^a   Harrison, Paul J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Affective disorder; Autoradiography; Bipolar disorder; Depression; Neurokinin 1

Indexed keywords

NEUROKININ 1 RECEPTOR; SUBSTANCE P; SUBSTANCE P RECEPTOR;

ADULT; AFFECTIVE NEUROSIS; AGED; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CINGULATE GYRUS; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; SCHIZOPHRENIA;

ADULT; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; FEMALE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; RECEPTORS, NEUROKININ-1; SCHIZOPHRENIA;

EID: 0034653187     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00264-4     Document Type: Article

References (14)

1. Aguiar M.S., Brandao M.L. Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal grey on the behaviour of rats in the plus maze test. Physiol Behav. 60:1996;1183-1186.
2. 125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain. Neuroscience. 18:1986;857-875.
3. Benes F.M. Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain. Schizophr Bull. 24:1998;219-230.
4. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology. 15:1996;442-455.
5. Burnet P.W.J., Eastwood S.L., Harrison P.J. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain A comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia . Neurochem Int. 30:1997;565-574.
6. Drevets W.C., Ongur D., Price J.L. Neuroimaging abnormalities in the subgenual prefrontal cortex Implications for the pathophysiology of familial mood disorders . Mol Psychiatry. 3:1998;220-226.
7. Enserink M. Can the placebo be the cure? Science. 284:1999;238-240.
8. File S.E. Anxiolytic action of a neurokinin 1 receptor anatagonist in the social interaction test. Pharmacol Biochem Behav. 58:1997;747-752.
9. Kramer M.S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J.J., et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 281:1998;1640-1645.
10. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 95:1998;13290-13295.
11. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 45:1999;1085-1098.
12. 125I] BH-substance P in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 22:1998;1295-1299.
13. Simpson M.D.C., Lubman D.I., Slater P., Deakin J. Autoradiography with [3H]8-OH-DPAT reveals localised increases in ventral prefrontal cortex in schizophrenia. Biol Psychiatry. 39:1996;919-928.
14. Vogt B.A., Nimchinsky E.A., Vogt L.J., Hof P.R. Human cingulate cortex Surface features, flat maps and cytoarchitecture . J Comp Neurol. 359:1995;490-506.